A weaker negative correlation between CD47 mRNA expression and SLFN11 promoter methylation (p = 4.6 × 10−19) suggested that the regulation of SLFN11 expression in human prostate cancers by CD47 is mediated in part by this mechanism (Figure 9C). This evidence concerns the gene SLFN11 and prostate carcinoma.